The study was designed to include participants taking PPIs and that were IBD and cancer free at the start of the study and then followed up with the participants 12 years later for the two NHS cohorts and 5 to 9 years for the UK Biobank cohort
This is most dramatically illustrated through differences in the intake patterns of the same drug with different routes of administration 45,46,47,48,49,50,58 known as the rate hypothesis of addiction 49,59,60
Primary antibody (anti-GCSc 1:100 (SantaCruz, sc390811), anti-CD45 1:100 (Santa Cruz, sc1178), anti-F4/80 1:100 (Cell Signaling Technology, 70076), anti-DNA/RNA Damage 1:200 (Abcam, 62623), anti-NRF2 1:100 (Abcam, 31163) and anti-GGT1 1:200 (donated from M
10.1007/s00125-020-05288-0 39 TashiroY.SatoK.WatanabeT.NohtomiK.TerasakiM.NagashimaM.et al (2014)